You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Regulated upon Activation, Normal T-cell Expressed and Secreted (RANTES)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Synovial Fluid Sleep Study

Enrolling by invitation
  • Sleep
    • New York, New York
      NYU Langone Health
    Aug 1, 2022

    Overweight and Obesity, Child Obesity, Hypertension Trial in Warszawa (Vegetable and fruit mousse enriched with a fiber

    Recruiting
    • Overweight and Obesity
    • +3 more
    • Vegetable and fruit mousse enriched with a fiber preparation from potato starch with prebiotic properties
    • +2 more
    • Warszawa, Poland
      The Childen's Memorial Health Institute
    Apr 20, 2022

    Inflammation After Laparoscopic Robot-assisted Surgery for

    Recruiting
    • Locally Advanced Rectal Cancer
    • Abdominoperineal Resection
      • Oslo, Norway
        The Norwegian Radium Hospital Oslo University Hospital
      Nov 17, 2021

      HLA-DR in Cell Cultures Isolated From Primary Squamous Cell

      Active, not recruiting
      • Squamous Cell Carcinoma of the Head and Neck
      • Cancer
      • cell culture
      • Roma, Lazio, Italy
        Fondazione Policlinico Universitario Gemelli, Irccs
      Sep 11, 2023

      Pancreatic Cancer Trial in Shatin (MSLN CART)

      Not yet recruiting
      • Pancreatic Cancer
      • MSLN CART
      • Shatin, N.t., Hong Kong
        Endoscopy Centre, Prince of Wales Hospital
      Sep 19, 2023

      Blood Pressure, Lung Function, Inflammation Trial in Beijing (Air cleaner use method 1, Air cleaner use method 2)

      Completed
      • Blood Pressure
      • +3 more
      • Air cleaner use method 1
      • Air cleaner use method 2
      • Beijing, China
        Department of Occupational & Environmental Health Sciences, Scho
      Oct 7, 2021

      Digestive Tumor Trial (TM4SF1-positive chimeric antigen receptor T-cell therapy)

      Not yet recruiting
      • Digestive Tumor
      • TM4SF1-positive chimeric antigen receptor T-cell therapy
      • (no location specified)
      Dec 21, 2022

      COVID-19 Pneumonia Trial in Wenzhou (Extracellular Vesicles from Mesenchymal Stem Cells)

      Recruiting
      • COVID-19 Pneumonia
      • Extracellular Vesicles from Mesenchymal Stem Cells
      • Wenzhou, Zhejiang, China
        The First Affiliated Hospital of Wenzhou Medical University
      Mar 27, 2023

      Dry Eye Disease Trial in Oslo (Thealoz Duo (combination of trehalose and hyaluronate) eye drop and Hyabak (hyaluronate) eye

      Recruiting
      • Dry Eye Disease
      • Thealoz Duo (combination of trehalose and hyaluronate) eye drop and Hyabak (hyaluronate) eye drop
      • Oslo, Norway
        The Norwegian Dry Eye Clinic
      Jun 27, 2022

      Mesothelioma, Mesotheliomas Pleural, Mesothelioma, Malignant Trial in Bethesda, Nashville (TC-510, Fludarabine,

      Recruiting
      • Mesothelioma
      • +14 more
      • TC-510
      • +2 more
      • Nashville, Tennessee
        Sarah Cannon Research Institute
      Jul 14, 2022

      Klotho _ LRP-6 _ Gastric Adenocarcinoma

      Not yet recruiting
      • Gastric Adenocarcinoma
      • +2 more
      • Prognostic study
      • (no location specified)
      Jan 29, 2023

      Advanced Hepatocellular Carcinoma Trial in Shenzhen (GPC3 CAR-T cells)

      Recruiting
      • Advanced Hepatocellular Carcinoma
      • GPC3 CAR-T cells
      • Shenzhen, Guangdong, China
        Li Yu
      Nov 17, 2022

      T-Cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Angioimmunoblastic T-cell Lymphoma Trial in Saint Louis (WU-CART-007)

      Not yet recruiting
      • T-Cell Non-Hodgkin Lymphoma
      • +14 more
      • WU-CART-007
      • Saint Louis, Missouri
        Washington University School of Medicine
      Jan 17, 2023

      Triple Negative Breast Cancer Trial (Cryoablation, Cryoablation combined with PD1 Inhibitor)

      Not yet recruiting
      • Triple Negative Breast Cancer
      • Cryoablation
      • Cryoablation combined with PD1 Inhibitor
      • (no location specified)
      Mar 28, 2023

      T Lymphoblastic Leukemia/Lymphoma Trial in Shenzhen (CD7 CAR-T cells)

      Recruiting
      • T Lymphoblastic Leukemia/Lymphoma
      • CD7 CAR-T cells
      • Shenzhen, Guangdong, China
        Li Yu
      Nov 11, 2022

      Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia, Lymphoma, B-Cell Trial run by the National Cancer Institute

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • +2 more
      • Anti-CD19 and anti-CD20 bicistronic CAR T- cells
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Apr 10, 2023

      Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

      Not yet recruiting
      • Solid Tumor, Adult
      • +19 more
      • A2B694
      • xT CDx with HLA-LOH Assay
      • Duarte, California
      • +9 more
      Sep 22, 2023

      B Cell Malignancies Trial in Shenzhen (bi-4SCAR CD19/79b T cells)

      Recruiting
      • B Cell Malignancies
      • bi-4SCAR CD19/79b T cells
      • Shenzhen, Guangdong, China
        Shenzhen Geno-immune Medical Institute
      Jun 28, 2022

      Serum Neurofilament Light asMarker for Brain Injury in

      Recruiting
      • Neurotoxicity
        • Saint Louis, Missouri
          Washington University School of Medicine
        Oct 10, 2022

        Pulmonary Immune Cell-microbiome Interactions in Healthy Lung

        Recruiting
        • Healthy
        • Bronhcoalvelar lavage
        • Hvidovre, Denmark
          Hvidovre Hospital, University of Copenhagen
        Apr 27, 2023

        Patients Undergoing CAR-T Cell Therapy (CAR_21_01)

        Recruiting
        • CAR-T Therapy Complications
          • Bologna, Italy
            IRCC, University Hospital of Bologna
          Mar 18, 2022

          Advanced Solid Tumors Trial in Chongqing (TC-N201 cells, IL-2, Fludarabine)

          Recruiting
          • Advanced Solid Tumors
          • TC-N201 cells
          • +4 more
          • Chongqing, China
            TCRCure Biopharma Ltd.
          May 25, 2023

          Immune Activation and Latent HIV Reservoir Size Between People

          Enrolling by invitation
          • HIV-1-infection
          • +3 more
          • Venipuncture
          • +4 more
          • Seattle, Washington
            University of Washington Positive Research and the Gastroenterol
          Oct 14, 2022

          d to Reveal Heterogeneity of Secondary Hyperparathyroidism

          Not yet recruiting
          • Secondary Hyperparathyroidism
          • Single-cell sequencing
          • (no location specified)
          Nov 12, 2023

          Bio-CAR-T BS Study

          Recruiting
          • Diffuse Large B Cell Lymphoma (DLBCL)
          • +2 more
            • Brescia, Italy
              ASST Spedali Civili di Brescia
            May 5, 2022